Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy

Table 5

Analysis of influencing factors of CEA change magnitude during chemotherapy.

Factor	Change magnitude of CEA	Univariate analysis		Multivariate analysis
		Age
≤57		0.353	0.554
>57
Menstruation
Yes		1.229	0.271
No
Comorbidities
No		2.061	0.155
Yes
BMI
≤24		0.136	0.713
>24
Tumor size
≤2 cm
>2 cm
Nodal status
0		7.560	0.001	15.117	0.000
1-3
≥ 4
HR status
Positive		8.079	0.006	14.834	0.000
Negative
ALT change magnitude
≤0.13	0.47 ± 0.48	0.294	0.589
>0.13	0.42 ± 0.48
AST change magnitude
≤0.05		0.632	0.429
0.05
rGT change magnitude
≤0.35		8.974	0.004	8.559	0.004
>0.35
Triglyceride change magnitude
≤0.18		0.043	0.835
>0.18
Cholesterol change magnitude
≤0.077		0.065	0.799
>0.077
Fasting blood glucose change magnitude
≤0.05		1.113	0.294
>0.05
Initial WBC
≤6.27		0.045	0.833
>6.27
Initial NEUT
≤3.50		0.855	0.358
>3.50
Initial MONO
≤0.29		0.298	0.586
>0.29
Initial LY
≤1.95		2.010	0.160
>1.95
Initial PLT/LY
≤117.54		0.203	0.654
>117.54
Initial NEUT/LY
≤1.74		4.900	0.029	7.078	0.009
>1.74
Initial LY/MONO
≤6.61	0.45 ± 0.48	0.000	0.982
>6.61	0.45 ± 0.49
Initial SII
≤410.69		1.007	0.318
>410.69